Cargando…

Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report

BACKGROUND: Conversion surgery for initially unresectable gallbladder cancer is rarely performed due to the low response rate for systemic chemotherapy, and a pathological complete response is seldom achieved. CASE PRESENTATION: A 67-year-old woman with jaundice was referred to our hospital and diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yuya, Ashida, Ryo, Sugiura, Teiichi, Ohgi, Katsuhisa, Yamada, Mihoko, Otsuka, Shimpei, Todaka, Akiko, Uesaka, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789988/
https://www.ncbi.nlm.nih.gov/pubmed/35079922
http://dx.doi.org/10.1186/s40792-022-01375-z
_version_ 1784639890085904384
author Miura, Yuya
Ashida, Ryo
Sugiura, Teiichi
Ohgi, Katsuhisa
Yamada, Mihoko
Otsuka, Shimpei
Todaka, Akiko
Uesaka, Katsuhiko
author_facet Miura, Yuya
Ashida, Ryo
Sugiura, Teiichi
Ohgi, Katsuhisa
Yamada, Mihoko
Otsuka, Shimpei
Todaka, Akiko
Uesaka, Katsuhiko
author_sort Miura, Yuya
collection PubMed
description BACKGROUND: Conversion surgery for initially unresectable gallbladder cancer is rarely performed due to the low response rate for systemic chemotherapy, and a pathological complete response is seldom achieved. CASE PRESENTATION: A 67-year-old woman with jaundice was referred to our hospital and diagnosed with unresectable gallbladder cancer with extra-regional lymph node metastasis after examinations. After biliary decompression, gemcitabine plus cisplatin therapy was started. The tumor marker levels markedly decreased, and imaging studies revealed a reduction in the primary tumor and metastatic lymph nodes. The primary tumor and metastatic lymph node were still shrunk at 4 years after the start of gemcitabine plus cisplatin therapy, so we decided to perform conversion surgery. Gallbladder bed resection and lymph node dissection were performed. The pathological findings of the resected specimen showed only partial fibrosis in the gallbladder wall and no malignant findings in the dissected lymph nodes, indicating a pathological complete response. As of 24 months after the operation, she is alive without recurrence. CONCLUSION: Although there have been only a few reports of conversion surgery for initially unresectable gallbladder cancer, it may be worthwhile to perform chemotherapy with the potential goal of subsequent conversion surgery.
format Online
Article
Text
id pubmed-8789988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87899882022-02-02 Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report Miura, Yuya Ashida, Ryo Sugiura, Teiichi Ohgi, Katsuhisa Yamada, Mihoko Otsuka, Shimpei Todaka, Akiko Uesaka, Katsuhiko Surg Case Rep Case Report BACKGROUND: Conversion surgery for initially unresectable gallbladder cancer is rarely performed due to the low response rate for systemic chemotherapy, and a pathological complete response is seldom achieved. CASE PRESENTATION: A 67-year-old woman with jaundice was referred to our hospital and diagnosed with unresectable gallbladder cancer with extra-regional lymph node metastasis after examinations. After biliary decompression, gemcitabine plus cisplatin therapy was started. The tumor marker levels markedly decreased, and imaging studies revealed a reduction in the primary tumor and metastatic lymph nodes. The primary tumor and metastatic lymph node were still shrunk at 4 years after the start of gemcitabine plus cisplatin therapy, so we decided to perform conversion surgery. Gallbladder bed resection and lymph node dissection were performed. The pathological findings of the resected specimen showed only partial fibrosis in the gallbladder wall and no malignant findings in the dissected lymph nodes, indicating a pathological complete response. As of 24 months after the operation, she is alive without recurrence. CONCLUSION: Although there have been only a few reports of conversion surgery for initially unresectable gallbladder cancer, it may be worthwhile to perform chemotherapy with the potential goal of subsequent conversion surgery. Springer Berlin Heidelberg 2022-01-26 /pmc/articles/PMC8789988/ /pubmed/35079922 http://dx.doi.org/10.1186/s40792-022-01375-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Miura, Yuya
Ashida, Ryo
Sugiura, Teiichi
Ohgi, Katsuhisa
Yamada, Mihoko
Otsuka, Shimpei
Todaka, Akiko
Uesaka, Katsuhiko
Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title_full Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title_fullStr Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title_full_unstemmed Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title_short Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
title_sort pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789988/
https://www.ncbi.nlm.nih.gov/pubmed/35079922
http://dx.doi.org/10.1186/s40792-022-01375-z
work_keys_str_mv AT miurayuya pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT ashidaryo pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT sugiurateiichi pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT ohgikatsuhisa pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT yamadamihoko pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT otsukashimpei pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT todakaakiko pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport
AT uesakakatsuhiko pathologicalcompleteresponseachievedbygemcitabinepluscisplatintherapyforinitiallyunresectableadvancedgallbladdercanceracasereport